Quarterly report [Sections 13 or 15(d)]

EQUITY - Schedule of Equity Instruments Other than Options (Details)

v3.25.1
EQUITY - Schedule of Equity Instruments Other than Options (Details) - $ / shares
 1 Months Ended 3 Months Ended
Feb. 28, 2025
Mar. 31, 2025
Derivative Liabilities Warrants    
Warrants    
Balance at end of period (in shares)   21,400,000
Warrants (derivative liabilities and equity)    
Warrants    
Balance at beginning of period (in shares)   71,918,536
Granted (in shares)   8,010,626
Balance at end of period (in shares)   79,929,162
Exercisable (in shares)   78,359,162
Weighted - Average Exercise Price    
Balance at beginning of period (in dollars per share)   $ 1.03
Granted (in dollars per share)   0.48
Balance at end of period (in dollars per share)   0.98
Exercisable (in dollars per share)   $ 0.98
Granted (in shares) 8,010,626  
Warrants (derivative liabilities and equity) | Non-Derivative (Equity) Warrants    
Warrants    
Balance at beginning of period (in shares)   50,518,536
Granted (in shares)   8,010,626
Balance at end of period (in shares)   58,529,162
Exercisable (in shares)   56,959,162
Warrants (derivative liabilities and equity) | Derivative Liabilities Warrants    
Warrants    
Balance at beginning of period (in shares)   21,400,000
Granted (in shares)   0
Balance at end of period (in shares)   21,400,000
Exercisable (in shares)   21,400,000